Peptidomic Workflow Applied to Cerebrospinal Fluid Analysis

Ziganshin, R., et al. Peptidomic Workflow Applied to Cerebrospinal Fluid Analysis, Cerebrospinal Fluid (CSF) Proteomics. Volume 2044, 111-118

Proteo-peptidomic profiling of biofluids is used to identify disease biomarkers and to study molecular mechanisms of pathology development. Previously, we studied changes in cerebrospinal fluid (CSF) and blood plasma associated with Guillain-Barre syndrome (GBS)—a rare and severe disorder of the peripheral nervous system with an unknown etiology. Here, we describe the workflow for the analysis of endogenous peptides from CSF. The procedure covers sample preparation, liquid chromatography-mass spectrometry (LC-MS) analysis, and bioinformatics analysis and allows identification of more than 1100 peptides from 181 protein groups in ~3 h from a single CSF sample derived from non-neurological, non-oncological patients.

Leave a Reply

Your email address will not be published.